Zoe Li
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
Also affiliated: United States Food and Drug Administration (2023–2025); Douglas Mental Health University Institute (2025); The Ohio State University (2018–2022); Universitatea Națională de Știință și Tehnologie Politehnica București (2023); University of Glasgow (2024–2025); McMaster University (2017–2025)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Zoe Li's research focuses on the application of machine learning and deep learning techniques to address complex problems in toxicology, medical imaging, and infrastructure resilience. She has investigated the efficacy of these computational methods for predicting toxicity, segmenting brain tumor MRI images, and understanding recovery disparities following extreme weather events. Li's work also extends to environmental science, with publications examining the effects of reservoir systems on river basins in China and the impact of climate change on hydrological processes. Her research network includes significant collaboration with Tucker A. Patterson and Fan Dong at the National Center for Toxicological Research, with whom she has co-authored numerous publications. Li's scholarship metrics include an h-index of 13, with 38 total publications and 523 citations.
Metrics
- h-index: 13
- Publications: 38
- Citations: 544
Selected Publications
-
Developing predictive models for µ opioid receptor binding using machine learning and deep learning techniques (2025)
-
Computational Toxicology (2024)
-
Decoding the κ Opioid Receptor (KOR): Advancements in Structural Understanding and Implications for Opioid Analgesic Development (2024)
-
Fingerprinting Interactions between Proteins and Ligands for Facilitating Machine Learning in Drug Discovery (2024)
-
Machine learning and deep learning for brain tumor MRI image segmentation (2023)
-
Review of machine learning and deep learning models for toxicity prediction (2023)
-
Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment (2023)
-
QSAR models for predicting in vivo reproductive toxicity (2023)
-
EADB—A database providing curated data for developing QSAR models to facilitate the assessment of endocrine activity (2023)
-
Decision forest—a machine learning algorithm for QSAR modeling (2023)
-
Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor (2023)
Collaboration Network
Top Collaborators
- Review of machine learning and deep learning models for toxicity prediction
- Machine learning and deep learning for brain tumor MRI image segmentation
- Fingerprinting Interactions between Proteins and Ligands for Facilitating Machine Learning in Drug Discovery
- Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
- Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment
Showing 5 of 11 shared publications
- Review of machine learning and deep learning models for toxicity prediction
- Machine learning and deep learning for brain tumor MRI image segmentation
- Fingerprinting Interactions between Proteins and Ligands for Facilitating Machine Learning in Drug Discovery
- Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
- Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment
Showing 5 of 11 shared publications
- Review of machine learning and deep learning models for toxicity prediction
- Machine learning and deep learning for brain tumor MRI image segmentation
- Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
- Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment
- QSAR models for predicting in vivo reproductive toxicity
Showing 5 of 9 shared publications
- Review of machine learning and deep learning models for toxicity prediction
- Machine learning and deep learning for brain tumor MRI image segmentation
- Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
- QSAR models for predicting in vivo reproductive toxicity
- Decoding the κ Opioid Receptor (KOR): Advancements in Structural Understanding and Implications for Opioid Analgesic Development
Showing 5 of 9 shared publications
- Review of machine learning and deep learning models for toxicity prediction
- Machine learning and deep learning for brain tumor MRI image segmentation
- Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment
- QSAR models for predicting in vivo reproductive toxicity
- Decoding the κ Opioid Receptor (KOR): Advancements in Structural Understanding and Implications for Opioid Analgesic Development
Showing 5 of 8 shared publications
- Fingerprinting Interactions between Proteins and Ligands for Facilitating Machine Learning in Drug Discovery
- Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
- Decoding the κ Opioid Receptor (KOR): Advancements in Structural Understanding and Implications for Opioid Analgesic Development
- Fingerprinting Interactions between Proteins and Ligands for Facilitating Machine Learning in Drug Discovery
- Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
- Decoding the κ Opioid Receptor (KOR): Advancements in Structural Understanding and Implications for Opioid Analgesic Development
- Review of machine learning and deep learning models for toxicity prediction
- Machine learning and deep learning for brain tumor MRI image segmentation
- Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment
- Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
- Decoding the κ Opioid Receptor (KOR): Advancements in Structural Understanding and Implications for Opioid Analgesic Development
- Decision forest—a machine learning algorithm for QSAR modeling
- EADB—A database providing curated data for developing QSAR models to facilitate the assessment of endocrine activity
- Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment
- Decision forest—a machine learning algorithm for QSAR modeling
- Review of machine learning and deep learning models for toxicity prediction
- Decision forest—a machine learning algorithm for QSAR modeling
- Decision forest—a machine learning algorithm for QSAR modeling
- Computational Toxicology
- Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment
- Developing predictive models for µ opioid receptor binding using machine learning and deep learning techniques
- Decision forest—a machine learning algorithm for QSAR modeling
Similar Researchers
Based on overlapping research topics